TABLE 2.
Proportion of subjects with VF or maintenance of VS according to ARV-naive status, VL at baseline, and NVP Ctrough
| Characteristic | Value for subject with:
|
P value | |
|---|---|---|---|
| VF | VS | ||
| No. of subjects (%) | 90 (50.56) | 88 (49.43) | |
| Time (days) with undetectable VLa | 300 (146-456) | 1,116 (928-1607) | <0.0001c |
| No. of naive subjects (%) | 17 (18.8) | 42 (47.7) | <0.0001b |
| No. of subjects with VLs of <50 copies/ml at baselinea | 4 (4.4) | 31 (35.2) | <0.0001b |
| NVP Ctrough (ng/ml)a | 3,894 (2,873-5,195) | 5,419 (3,869-7,248) | 0.001c |
| No. of subjects with NVP Ctrough of >4,300 ng/ml (%) | 33 (36.6) | 60 (68.18) | <0.0001b |
Values are expressed as medians IQRs.
Based on a chi-square test.
Based on Student's t test.